Common symptoms of HCL includes persistently feeling tired, weakness, weight loss for no reason, shortness of breath, excessive sweating (most often at night), swollen lymph nodes, frequent infections and fevers, small red spots on the skin. The main treatment for hairy cell leukemia is chemotherapy, purine analog drugs either cladribine (2-CdA) or pentostatin, monoclonal antibody rituximab, surgery or interferon alpha.
Based on statistics, overall, around 90 out of every 100 people diagnosed with hairy cell leukaemia (90%) will survive for 5 years or more after they are diagnosed. The disease occurs predominantly in middle-aged men, with a median age of 52 years. The male-to-female ratio is 4:1 to 5:1.